Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Thoracic Epidural Analgesia in Open Gynecologic Surgery
NCT04117074Phase 3Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Apr 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Area Under the Curve of Visual Analog Scale Pain Intensity Scores and Total Opioid Consumption. Started Apr 2021; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04117074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117074.